Healthcare Costs and Life-years Gained From Treatments Within the Advancing Cryptococcal Meningitis Treatment for Africa (ACTA) Trial on Cryptococcal Meningitis: A Comparison of Antifungal Induction Strategies in Sub-Saharan Africa

BACKGROUND: Mortality from cryptoccocal meningitis remains high. The ACTA trial demonstrated that, compared with 2 weeks of amphotericin B (AmB) plus flucystosine (5FC), 1 week of AmB and 5FC was associated with lower mortality and 2 weeks of oral flucanozole (FLU) plus 5FC was non-inferior. Here, w...

詳細記述

保存先:
書誌詳細
出版年:Clin Infect Dis
主要な著者: Chen, Tao, Mwenge, Lawrence, Lakhi, Shabir, Chanda, Duncan, Mwaba, Peter, Molloy, Síle F, Gheorghe, Adrian, Griffiths, Ulla K, Heyderman, Robert S, Kanyama, Cecilia, Kouanfack, Charles, Mfinanga, Sayoki, Chan, Adrienne K, Temfack, Elvis, Kivuyo, Sokoine, Hosseinipour, Mina C, Lortholary, Olivier, Loyse, Angela, Jaffar, Shabbar, Harrison, Thomas S, Niessen, Louis W
フォーマット: Artigo
言語:Inglês
出版事項: Oxford University Press 2019
主題:
Articles and Commentaries
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6669289/
https://ncbi.nlm.nih.gov/pubmed/30863852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy971
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料